Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanislas Demuth

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Neuroinflammation|March 3, 2022
Treatment regimens for neuromyelitis optica spectrum disorder attacks: a retrospective cohort studyStanislas Demuth, Maxime Guillaume, Bertrand Bourre, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 24, 2023
Effect of Ocrelizumab on B- and T-Cell Receptor Repertoire Diversity in Patients With Relapsing Multiple Sclerosis From the Randomized Phase III OPERA TrialSarah A Laurent, Nicolas B Strauli, Erica L Eggers, et al.
JAMIA Open|May 14, 2026
PRIMUS: a precision medicine platform reusing clinical trials and registry data to support treatment selection in multiple sclerosisStanislas Demuth, Igor Faddeenkov, Julien Paris, et al.
JCI Insight|December 5, 2017
Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patientsErica L Eggers, Brady A Michel, Hao Wu, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Neuroinflammation|March 3, 2022
Treatment regimens for neuromyelitis optica spectrum disorder attacks: a retrospective cohort studyStanislas Demuth, Maxime Guillaume, Bertrand Bourre, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 24, 2023
Effect of Ocrelizumab on B- and T-Cell Receptor Repertoire Diversity in Patients With Relapsing Multiple Sclerosis From the Randomized Phase III OPERA TrialSarah A Laurent, Nicolas B Strauli, Erica L Eggers, et al.
JAMIA Open|May 14, 2026
PRIMUS: a precision medicine platform reusing clinical trials and registry data to support treatment selection in multiple sclerosisStanislas Demuth, Igor Faddeenkov, Julien Paris, et al.
JCI Insight|December 5, 2017
Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patientsErica L Eggers, Brady A Michel, Hao Wu, et al.
Pageof 2